跳到正文

VHCP Management EG, LLC 内部人交易:近期 SEC Form 4 交易

过去 18 个月,VHCP Management EG, LLC(CIK 1808518)在 2 家公司共报告 18 笔 SEC Form 4 内部人交易(最近一笔 2026-11-04)。

日期公司身份类型股数市值
2026-11-04Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入8,305$223,820
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入10,570$266,681
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入4,430$115,047
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入1,000$26,330
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入8,804$231,281
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入200$5,372
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入4.8M$0
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入24,560$630,701
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入28,379$740,976
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入1.9M$35.0M
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入8,261$222,799
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入8,729$225,557
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% 以上股东买入31,067$833,838
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% 以上股东卖出174,485$3.0M
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% 以上股东卖出160$2,805
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% 以上股东卖出21,386$379,815
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% 以上股东卖出15,417$290,148
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% 以上股东卖出3,183$60,859

来源:SEC Form 4 申报文件 · 截至 2026-11-04